Navigation Links
Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
Date:12/4/2012

CHAPEL HILL, N.C., Dec. 4, 2012 /PRNewswire/ -- With the election dust settled and healthcare reform moving forward, government agencies such as the Centers for Medicare and Medicaid Services (CMS) are in the process of planning and implementing structural changes that will considerably impact the pharmaceutical and medical device industries.

Facing a rapidly changing healthcare landscape, organizations will need to interact with a wider range of federal agencies and state entities like health insurance exchanges and Accountable Care Organizations that affect healthcare policy. While many pharmaceutical and device companies have engagement strategies for the FDA and CMS, the coming changes to the healthcare system mean industry will need to clarify and strengthen the roles of functions such as government affairs, public policy and managed markets.

Leading research and consulting firm Best Practices, LLC recently conducted a research study to illuminate winning strategies for navigating healthcare reform. The study - Managing Healthcare Reform: Winning Strategies for Engaging the Government Ecosystem That Shapes Healthcare Policy - identifies how companies in the healthcare industry can utilize their resources to cover and engage the various agencies and entities involved with public healthcare.

This study engaged executives from 23 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. Eight participants formed the Large Pharma Segment as well as the Mid-Cap Segment. The Emerging Pharma Segment consists of seven companies. In addition, deep-dive interviews were conducted with six participating companies to gather additional insights.

Best Practices, LLC is hosting a webinar on Thursday, December 6 and Tuesday, December 11 at 11 a.m. (EST) to highlight the findings from this timely study. Interested professionals can follow thi
'/>"/>

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New method for producing precursor of neurons, bone and other important tissues from stem cells
2. Medical Experts Who Participated in CSL Behrings Key Issues Dialogue Prefer Albumin for Fluid Management
3. Genesis Biopharma Issues Letter To Shareholders
4. FDA Issues Orphan Status Approval for PermaDerm®
5. California Healthcare Institute Issues Statement on Supreme Court Ruling on the Affordable Care Act
6. Clinical Site Services Chris Trizna Contributing Author in Diana Anderson-Fosters Newest Release Global Issues in Patient Recruitment and Retention
7. Amarantus BioSciences Issues CEO Letter to Shareholders
8. Precisely engineering 3-D brain tissues
9. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
10. Discovery Labs Reports Third Quarter Financial Results and Progress on Lead Programs
11. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , Collaboration with the ... in treatment of mastitis , ... to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will collaborate ... Service (ARS) to develop and trial products targeting the ...
(Date:5/20/2013)... 20, 2013 Oven Industries Inc. announces ... capabilities. The 5R6-900 benchtop controller has many outstanding user-friendly ... be plugged into the wall as a self-contained temperature ... distinctive detail makes the device unique, as well as ... temperature controller can also be used universally, which allows ...
(Date:5/20/2013)... 2013 Today, at the American Psychiatric Association ... James McGough , M.D., M.S., principal ... Institute for Neuroscience and Human Behavior and ... University of California Los Angeles (UCLA), and director of ... and ADHD at UCLA, presented the results of a ...
(Date:5/20/2013)... SAN DIEGO , May 20, 2013  Dr. ... the field of nucleic acid research, recently launched a ... Zone In with Zon ( zon.trilinkbiotech.com ), focuses on ... posts include interviews with industry thought leaders, discussions of ... publications and more. Dr. Zon (PhD ...
Breaking Biology Technology:Phosphagenics Signs Research Agreement with the Agricultural Research Service 2New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Dr. Gerald 'Jerry' Zon Launches New Blog for TriLink BioTechnologies 2
... Investment Conference on... -- HARBIN, China, Sept. 7 /PRNewswire-Asia-FirstCall/ -- ... ... --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... Calif., Sept. 7 / PRNewswire/ -- Transdel ... announced that Transdel management will present a company overview at ... York City on Monday, September 13, 2010 at 4:05 p.m. ... webcast via the Internet by visiting the Investor Relations section ...
... Exclusive Partnership Agreements for Immunotherapy Tablets in Japan -- ANTONY, France, September 6, 2010 ... ... --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
Cached Biology Technology:Weikang Bio-Technology to Present at Rodman and Renshaw's Annual Global Investment Conference on September 14th 2010 2Weikang Bio-Technology to Present at Rodman and Renshaw's Annual Global Investment Conference on September 14th 2010 3Weikang Bio-Technology to Present at Rodman and Renshaw's Annual Global Investment Conference on September 14th 2010 4Weikang Bio-Technology to Present at Rodman and Renshaw's Annual Global Investment Conference on September 14th 2010 5Weikang Bio-Technology to Present at Rodman and Renshaw's Annual Global Investment Conference on September 14th 2010 6Weikang Bio-Technology to Present at Rodman and Renshaw's Annual Global Investment Conference on September 14th 2010 7Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference 2Transdel Pharmaceuticals to Present at Rodman & Renshaw 12th Annual Healthcare Conference 3Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan 2Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan 3Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan 4Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan 5Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan 6Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan 7Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan 8Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan 9
(Date:5/20/2013)... of the planet, inhales carbon dioxide as it exudes oxygen. ... that eventually fall to the ground to decompose or get ... recently people believed much of the rain forest,s carbon floated ... ocean. University of Washington research showed a decade ago that ... open the question of how that was possible, since bark ...
(Date:5/20/2013)... University of Bristol and published online today in the ... how the brain and inner ear developed in dinosaurs. ... Sciences, together with Tom Hbner from the Niederschsische Landesmuseum ... year old dinosaurs. , The two palaeontologists studied different ... a very young (juvenile) individual of approximately three ...
(Date:5/19/2013)... of California, Davis have engineered a strain of photosynthetic ... They report their findings today at the 113th General ... this work, we used synthetic biology approaches to probe ... light energy for growth) cyanobacterial metabolism for the ability ... lead researcher on the study. He is part ...
Breaking Biology News(10 mins):Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3Fossil brain teaser 2
... newborn described as a "happy blue baby" because of ... small mark in medical history when one of her ... River mutation. Scientists have identified hundreds of mutations ... protein that carries oxygen in everyone,s red blood cells. ...
... Bethesda, MD "Super bugs," which can cause wide-spread disease ... conventional antibiotics, still have their weaknesses. A team of ... presented in lipid (fatty) mixtures can significantly boost the ... This discovery was published online in The FASEB ...
... has awarded the University of Colorado Boulder a ... of long-term ecological changes in Colorado,s high mountains, ... Awarded to CU-Boulder,s Institute of Arctic and ... and students, including undergraduates, to continue key environmental ...
Cached Biology News:Hematologist discovers, names the 'Toms River' blood mutation in N.J. family 2Scientists develop a fatty 'kryptonite' to defeat multidrug-resistant 'Super bugs' 2NSF awards CU-Boulder $5.9 million grant for alpine ecosystem research 2NSF awards CU-Boulder $5.9 million grant for alpine ecosystem research 3NSF awards CU-Boulder $5.9 million grant for alpine ecosystem research 4
OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture...
...
... interferons are cytopathic effect inhibition assays, also known ... include; tissue culture supernatents; serum from PK studies ... unit is defined as the quantity of interferon ... of viral infection by 50%. All ...
... interferons are cytopathic effect inhibition assays, also known ... include; tissue culture supernatents; serum from PK studies ... unit is defined as the quantity of interferon ... of viral infection by 50%. All ...
Biology Products: